Quantcast

Latest dialysis Stories

2014-07-24 08:34:37

RnRMarketResearch.com adds "Market Research Report on Global and Chinese Hemodialysis Machine Industry, 2009-2019" to its store. DALLAS, July 24, 2014 /PRNewswire-iReach/ -- Delivery of the Report will take 2-3 working days once order is placed. Photo - http://photos.prnewswire.com/prnh/20140723/129707 This is a professional and in-depth market survey on Global and Chinese Hemodialysis Machine industry. The report firstly reviews the basic information of Hemodialysis Machine...

2014-07-23 23:07:09

ChinaMarketResearchReports.com adds Latest Report on “China Hemodialysis Equipment Import and Export Report, 2013-2016” to its store. Complete report is available at http://www.chinamarketresearchreports.com/114870.html. Dallas, TX (PRWEB) July 23, 2014 Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure. The Chinese hemodialysis equipment market shows a high concentration, mainly...

2014-07-23 16:27:28

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Renal Dialysis Equipment: Technologies and Global Marketshttps://www.reportbuyer.com/product/2070056/Renal-Dialysis-Equipment-Technologies-and-Global-Markets.htmlREPORT HIGHLIGHTSThe global market for dialysis equipment and accessories was valued at $12.5 billion in 2012 and $13.4 billion in 2013. This market is expected to be valued at nearly $18.8 billion in 2018, rising at a five-year...

2014-07-20 23:00:20

The Firm is actively filing NaturaLyte and GranuFlo lawsuits on behalf of dialysis patients who allegedly suffered strokes, heart attacks and other cardiovascular problems after being administered the medications. New York, NY (PRWEB) July 20, 2014 Nearly 2,000 NaturaLyte and GranuFlo lawsuits (http://www.thegranuflolawsuit.com ) have now been filed in a federal litigation involving the dialysis medications, Bernstein Liebhard LLP reports. A Case List updated on July 15th indicates that...

2014-07-17 16:26:20

Analysis Shows Study Met Primary and All Secondary Endpoints THOUSAND OAKS, Calif., July 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a Phase 3 study evaluating AMG 416 (formerly known as velcalcetide) for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints. The primary endpoint was the proportion of patients with > 30 percent reduction from...

2014-07-16 12:27:25

NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One(TM). Traveling in the NxStage Freedom...

2014-07-11 12:24:32

Hospital successfully transplants the first liver dialysis patient in the state HOUSTON, July 11, 2014 /PRNewswire-USNewswire/ -- Texas Children's Hospital is excited to announce the first use of an extracorporeal liver support therapy in Texas for children with acute liver failure. The hospital now offers the Molecular Adsorbent Recirculating System (MARS®), a liver dialysis therapy, which helped a 9-year-old patient with hepatic coma become healthy enough to be a candidate for...

2014-07-10 12:28:45

Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of...

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate Nefecon(R) issued in the key markets United States, Europe, China and Hong Kong. A patent is pending in Japan. Nefecon is a potential disease-modifying treatment for patients with primary IgA nephropathy at risk of developing end-stage renal disease. Nefecon has shown positive results in an...

2014-07-09 08:27:28

World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities. http://photos.prnewswire.com/prnvar/20140303/LA75036LOGO-b DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD)...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related